Navigation Links
Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research
Date:10/8/2007

LITTLE ROCK, Ark., Oct. 8 /PRNewswire-USNewswire/ -- A research study at the University of Arkansas for Medical Sciences (UAMS) is designed to establish one of the largest and most rapidly assembled groups of women to aid in the study of breast cancer occurrence.

Spit for the Cure involves the collection of saliva samples from thousands of women and is being conducted with the support of the Arkansas Chapter of Susan G. Komen for the Cure. The saliva samples will be used to create a DNA database for future studies related to breast cancer risk and treatment. Participants also will be asked to answer a short questionnaire and indicate if they would be willing to participate in follow-up studies. All information will be kept confidential.

To participate, contact Susan Kadlubar, Ph.D., assistant professor of environmental and occupational health in the UAMS College of Public Health, at (501) 526-7957. Additional researchers leading the study are V. Suzanne Klimberg, M.D., director of the breast cancer program at the UAMS Winthrop P. Rockefeller Cancer Institute (formerly the Arkansas Cancer Research Center), and Kristy Bondurant, Ph.D., postdoctoral fellow.

"It has become clear that an individual's inherited profile and environmental exposures will decide, to a large degree, that individual's risk of developing breast cancer," Klimberg said. "We are working to obtain DNA samples from a representative group of Arkansas women that will be used to advance breast cancer research in a variety of areas."

Researchers will be allowed to access the samples and data linked by unique identification codes in order to address specific questions related to the factors affecting breast cancer risk and treatment, without having access to information that could identify participants.

"Because the study is noninvasive, it is easy to participate," Kadlubar said. "By collecting samples from women at Susan G. Komen for the Cure events, as well as in other locations, we hope to quickly assemble a large, representative DNA database that will benefit numerous research studies." Little Rock is home to one of the country's largest Komen Races for the Cure, with more than 40,000 women participants each year.

UAMS is the state's only comprehensive academic health center, with five colleges, a graduate school, a medical center, six centers of excellence and a statewide network of regional centers. UAMS has about 2,538 students and 733 medical residents. It is one of the state's largest public employers with about 9,600 employees, including nearly 1,000 physicians who provide medical care to patients at UAMS, Arkansas Children's Hospital, the VA Medical Center and UAMS' Area Health Education Centers throughout the state. UAMS and its affiliates have an economic impact in Arkansas of $5 billion a year. For more information, visit http://www.uams.edu.


'/>"/>
SOURCE University of Arkansas for Medical Sciences
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Ties Between Physicians and Drug Companies Still Too Strong: the Prescription Project Offers Solutions to Prevent Conflicts of Interest
2. MUSC Research Offers Hope for Those Resistant to Depression Treatment
3. New Report Illuminates Ampligens Unique Mechanism of Action
4. ZIOPHARM Presents Unique Mechanism Data for Indibulin at AACR
5. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
6. New Poll Shows Men, Women Incorrectly Blame Symptoms of Low Testosterone on Normal Aging
7. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
8. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
11. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... Ridgecrest Herbals makes it a point to lead ... reduce waste, and support renewable energy. They believe this is a crucial part of ... solutions for health issues, and maintain that destroying the environment in the pursuit of ...
(Date:4/24/2017)... ... ... , a national non-profit organization focusing on the prevention and early detection of breast and ... to announce Katie Thiede as their new Chief Executive Officer. In January, founder Lindsay Avner ... Board and launched a national search to find a visionary new leader to grow Bright ...
(Date:4/24/2017)... ... April 24, 2017 , ... The John P. McGovern Museum of Health and ... to track their cognitive health, and share results with their physicians. Members and guests ... the museum's website. , BrainCheck founder, Dr. David Eagleman, formerly at Baylor College of ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... within the telehealth industry, announces the company’s VideoMedicine mobile platform has launched Quick ... Available 24 hours a day, Quick Care provides patients with the option to ...
(Date:4/24/2017)... ... April 24, 2017 , ... MAP Health Management announced today ... people with addiction who are served by MAP’s patient engagement ecosystem. Lief Therapeutics ... monitors heart and breath rates to identify anxiety levels and can provide biofeedback ...
Breaking Medicine News(10 mins):